Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines

Anticancer Research

Volumn 26, Issue 3 A, 2006, Pages 2137-2142

  Tanic, Nikola ^a   Brkic, Gordana ^c   Dimitrijevic, Bogomir ^b   Dedovic Tanic, Nasta ^b   Gefen, Nir ^c   Benharroch, Daniel ^d   Gopas, Jacob ^c,d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

CD44; Differentially expressed genes; Drug resistance; LPPR 2; Melanoma; TCP 1 zeta 6A

Indexed keywords

CHAPERONIN; COMPLEMENTARY DNA; DNA FRAGMENT; GENE PRODUCT; HERMES ANTIGEN; HYALURONIC ACID; LIPID; MESSENGER RNA; PHOSPHATASE; PHOSPHATE; PRIMER DNA; TIOGUANINE;

ARTICLE; DIFFERENTIAL DISPLAY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SELECTION; GENETIC TRAIT; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MELANOMA CELL; MOLECULAR CLONING; PHENOTYPE; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CELL LINE, TUMOR; DNA, COMPLEMENTARY; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER;

EID: 33745596411     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nessling M, Kern MA, Schadendorf D and Lichter P: Association of genomic imbalances with resistance to therapeutic drugs in human melanoma cell lines. Cytogenet Cell Genet 87: 286-290, 1999.
2. Bradbury PA and Middleton MR: DNA repair pathways in drug resistance in melanoma. Anticancer Drugs 15: 421-426, 2004.
3. Soengas MS and Lowe SW: Apoptosis and melanoma chemoresistance. Oncogene 22: 3138-3151, 2003.
4. Carr KM, Bittner M and Trent JM: Gene-expression profiling in human cutaneous melanoma. Oncogene 22: 3076-3080, 2003.
5. Grottke C, Mantwill K, Dietel M and Herman L: Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplstic agents. Int J Cancer 88: 535-546, 2000.
6. Wittig R, Nessling M, Will RD, Mollenhauer J, Salowsky R, Munstermann E, Schick M, Helmbach H, Gschwendt B, Korn B, Kioschis P, Lichter P, Schadendorf D and Poustka A: Candidate genes for cross-resistance against DNA-damaging drugs. Cancer Res 62: 6698-6705, 2002.
7. Brkic G, Gopas J, Tanic N, Dedovic-Tanik N, Benharroch D, Finkelstein-Jaworowsky E and Dimitrijevic B: Genomic instability in drug resistant human melanoma cell lines detected by Alu-I-arbitrary-primed PCR. Anticancer Res 23: 2601-2608, 2003.
8. Sinha P, Poland J, Kohl S, Schnolzer M, Helmbach H, Hutter G, Lage H and Schadendorf D: Study of the development of chemoresistance in melanoma cell lines using proteome analysis. Electrophoresis 24: 2386-2404, 2003.
9. Pak BJ, Lee J, Thai BL, Fuchs SY, Shaked Y, Ronai Z, Kerbel RS and Ben-David Y: Radiation resistance of human melanoma analysed by retroviral insertional mutagenesis reveals a possible role for dopachrome tautomerase. Oncogene 23: 30-38, 2004.
10. Liang P: Factors ensuring successful use of differential display. A companion to Methods in Enzymology 16: 361-364, 1998.
11. Tanic N, Dedovic N, Vujosevic M and Dimitrijevic B: DNA profiling of B chromosomes from the yellow-necked mouse Apodemus flavicollis (Rodentia, Mammalia). Genome Res 10: 55-61, 2000.
12. Martin KJ and Pardee AB: Principles of differential display. Meth Enzymol 303: 234-259, 1999.
13. McClelland M and Welsh J: DNA fingerprinting by arbitrarily primed PCR. PCR Meth Applicat 4: S59-S65, 1994.
14. Delta, DeltaCT method. Methods 25: 402-408, 2001.
15. Spiess C, Meyer AS, Reissmann S and Frydman J: Mechanisms of the eukaryotic chaperonin: protein folding in the chamber of secrets. Trends Cell Biol 14: 598-604, 2004.
16. Guenther MG, Yu J, Kao, Yen TJ and Lazar MA: Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex. Genes Dev 16: 3130-3135, 2002.
17. Roperch JP, Lethrone F, Prieur S, Piouffre L, Israeli D, Tuynder M, Nemani M, Pasturaud P, Gendron MC, Dausset J, Oren M, Amson RB and Telerman A: SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1). Proc Natl Acad Sci USA 96: 8070-8073, 1999.
18. Hansen WJ, Ohh M, Moslehi J, Kondo K, Kaelin WG and Welch WJ: Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity. Mol Cell Biol 22: 1947-1960, 2002.
19. Csermely P: Chaperone overload is a possible contributor to 'civilization diseases'. Trends Genetics 17: 701-704, 2001.
20. Bartolazzi AR, Peach A, Aruffo A and Stamenkovic: Interaction between CD44 and hyaluronan is directly implicated in the regulation of tumor development. J Exp Med 180: 53-66, 1994.
21. Bates RC, Edwards NS, Burns GF and Fisher DE: A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res 61: 5275-5283, 2001.
22. Molinari A, Calcabrini A, Meschini S, Marra M, Stringaro A, Toccacieli L, Cianfriglia M and Arancia G: What is the relationship between P-glycoprotein and adhesion molecule expression in melanoma cells? Melanoma Res 12: 109-114, 2002.
23. Alderton F, Darroch P, Sambi B, McKie A, Ahmed IS, Pyne N and Pyne S: G-proteincoupled receptor stimulation of the p42/p44 mitogen activated protein kinase pathway is attenuated by lipid phosphate phosphatases 1, 1a and 2 in human embryonic kidney 293 cells. J Biol Chem 276: 13452-13460, 2001.
24. Chakravarti A, Chakladar A, Delaney MA, Latham DE and Loeffler JS: The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Cancer Res 62: 4307-4315, 2002.
25. McArdle L, Rafferty MM, Satyamoorthy K, Maelandsmo GM, Dervan PA, Herlyn M and Easty DJ: Microarray analysis of phosphatase gene expression in human melanoma. Br J Dermatol 152: 925-930, 2005.